Trimazosin

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Trimazosin
Trimazosin.svg
Clinical data
ATC code C02CA03 (WHO)
Identifiers
IUPAC name: (2-Hydroxy-2-methylpropyl) 4-(4-amino-6,7,8-trimethoxyquinazolin-2-yl)piperazine-1-carboxylate
CAS Number 53746-46-6 YesY
PubChem (CID) 37264
ChemSpider 34203 N
UNII 31L760807H YesY
KEGG D08212 N
ChEMBL CHEMBL513301 N
Chemical and physical data
Formula C20H29N5O6
Molar mass 435.47 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Trimazosin is a sympatholytic alpha blocker.[1][2]

References[edit]

  1. ^ van Kalken CK, van der Meulen J, Oe PL, Vriesendorp R, Donker AJ (1986). "Pharmacokinetics of trimazosin and its effects on blood pressure, renal function and proteinuria during short-term therapy of patients with impaired renal function and hypertension". Eur. J. Clin. Pharmacol. 31 (1): 63–8. doi:10.1007/BF00870988. PMID 3780829. 
  2. ^ U.S. Patent 3,669,968